Home / Posts Tagged "Srinivas Sadu"

Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024. Srinivas Sadu, a seasoned professional with

READ MORE